Lavipharm
About Lavipharm
Categories
-
GR
-
2019On CPHI since
-
250 - 499Employees
Company types
Meet us at
CPHI Frankfurt 2025
Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
Products from Lavipharm (2)
-
Product Nitrong, Trinipatch, Nitrosylon
A latest generation nitroglycerin patch for the treatment of coronary artery disease and heart failure. Transdermal Drug Delivery Systems (TDDS) are one of the pharmaceutical technologies, in which Lavipharm is actively and successfully engaged. TDDSs are placed on the skin and allow specific drug subs... -
Product Fentadur, Dolfen, Durfenta, Opiodur
A fentanyl transdermal delivery system, developed by Lavipharm's research laboratories in the USA and approved by the FDA, is a small, thin and easy to adhere patch for the management of chronic pain. It is designed to deliver the analgesic substance fentanyl safely and effectively through the skin. ...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance